Alternatives to LunaRx

A recently-rebranded provider (formerly Piper, now Join Polly) with a flat, dose-independent price for both molecules — $135/mo semaglutide, $199/mo tirzepatide — and one of the few among the providers we track to publicly name its compounding pharmacies (Hallandale Pharmacy, VialsRx).

A multi-category telehealth shop with some of the lowest disclosed GLP-1 starting prices in this batch — from $99/mo semaglutide, $140/mo tirzepatide — though the site's own disclosure that pricing 'may vary' means the real ongoing cost isn't fully locked in.

One of the lowest disclosed GLP-1 starting prices in this round — from $99/mo semaglutide, $133/mo tirzepatide — with an explicit no-membership, no-hidden-fee claim, though the real ongoing rate at a working dose isn't confirmed.

A named-Medical-Director program licensed in all 50 states, from $99/mo semaglutide and $183/mo tirzepatide, with no membership required — but it carries a 2025 FDA warning letter over how it described its compounded medication, and both prices are 'From' starting prices rather than a guaranteed working-dose rate.

Novi's month-to-month rates are $149 semaglutide and $179 tirzepatide, flat at every dose — but almost every number the site advertises is a prepay term price divided by its term. The '$88/mo' headline on Novi's own product page is the twelve-month row, and its homepage quotes '$133/mo' under a countdown, a figure that is not a monthly price on either product page. Its intake then serves a higher variant again. Its Terms require a three-month non-refundable commitment while its help center says there are no commitments at all, so the two things you most need to know — what leaves the account, and when you can stop — are the two things Novi contradicts itself on.

FDA warning letter #721472 (Feb. 2026), which names newself.com. A flat, dose-independent price for both molecules — $99.97/mo semaglutide, $144.49/mo tirzepatide, same price at every dose — nationwide, though it requires 3 months upfront.

Telehealth GLP-1 programs in all 50 states from $149 a month, including a dedicated microdose protocol alongside standard semaglutide and tirzepatide. That figure is a floor rather than a rate, it is labeled a limited-time offer, and no treatment page publishes a price for any specific molecule, so the real cost is not knowable until you finish a two-minute eligibility check. Superior Remedies charges nothing if you are not approved, titrates the dose to how you respond rather than shipping a fixed refill, and attributes its compounding to state-licensed pharmacies it does not name.

A fully itemized pricing table — as low as $96/mo semaglutide or $142/mo tirzepatide on the annual plan — from the same medical group behind Cora Health, another new addition this batch.

This record changed completely between checks, and mostly for the better. The founding-member framing that dominated it a week ago is gone: read live on 2026-08-26 KERNX simply says "Semaglutide starts at $129/month and Tirzepatide starts at $229/month. Pricing varies by prescribed dose. No membership fee. No required 3 month plan." What has not gone is the cost outside those figures, and KERNX is unusually straight about it — a provider consultation fee applies when treatment is approved, at $25 for a message-based review, $35 for a standard live visit or $60 for a complex live visit. Two more things this record previously had wrong. It does say where it operates: licensed providers in all 50 states, repeated in its banner and its FAQ. And it publishes a real timeline: a free five-minute assessment, provider review typically within 24 hours, pharmacy processing 1–2 business days and transit 2–3, so most first orders arrive within three to five business days of approval. It also says nothing is charged until a provider approves you.